PubMed:22705061
Annnotations
PubMed_ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 171-352 | DRI_Background | denotes | Concurrent supplement of estradiol and progesterone has been shown to reduce the cardiac sensitivity to class III antiarrhythmic agent-induced arrhythmias in ovariectomized rabbits. |
T2 | 353-643 | DRI_Background | denotes | To understand the underlying cardiac electrophysiological mechanisms of the hormones, present study explored the modulation of progesterone and estradiol on repolarization and its frequency dependence in papillary muscles of female rabbit right ventricles by glass microelectrode technique. |
T3 | 644-890 | DRI_Outcome | denotes | Results showed that progesterone shortened action potential duration for 90% repolarization (APD(90)) whereas estradiol prolonged APD(90) and those actions on APD(90) were concentration-dependent for both hormones at 1.0-30 μM (P<0.05 or P<0.01). |
T4 | 891-1004 | DRI_Approach | denotes | Further, the action of both hormones on APD(90) was found to be dependent on stimulation frequencies (0.2-3.3Hz). |
T5 | 1005-1343 | DRI_Outcome | denotes | The shortening of APD(90) by progesterone (10 μM) was enhanced with the increase in frequencies reaching a statistic significance at frequencies ≥1.0 Hz, whereas the prolongation of APD(90) by estradiol (3 μM) was weakened with the increase in frequencies and the significant change was observed at frequencies ≤2.0 Hz (P<0.05 or P<0.01). |
T6 | 1344-1660 | DRI_Outcome | denotes | More interestingly, the relative change of APD(90) and the incidence of early afterdepolarization induced after by dofetilide (0.1 μM), a class III antiarrhythmic agent, were significantly less or lower in the papillary muscles pretreated with progesterone than in those pretreated with estradiol (P<0.01 or P<0.05). |
T7 | 1661-1768 | DRI_Outcome | denotes | In conclusion, progesterone has a reverse modulating affect on cardiac repolarization to that of estradiol. |
T8 | 1769-1897 | DRI_Outcome | denotes | By acceleration of ventricular repolarization, progesterone may reduce the susceptibility of females to class III antiarrhythmic |
T9 | 1927-1937 | DRI_Outcome | denotes | affection. |
Goldhamster2_Cellosaurus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 223-226 | CVCL_6758|Undefined_cell_line_type|Cricetulus griseus | denotes | has |
T2 | 223-226 | CVCL_E689|Transformed_cell_line|Homo sapiens | denotes | has |
T3 | 737-740 | CVCL_E459|Transformed_cell_line|Homo sapiens | denotes | APD |
T4 | 774-777 | CVCL_E459|Transformed_cell_line|Homo sapiens | denotes | APD |
T5 | 803-806 | CVCL_E459|Transformed_cell_line|Homo sapiens | denotes | APD |
T6 | 865-867 | CVCL_J925|Hybridoma|Mus musculus | denotes | 30 |
T7 | 931-934 | CVCL_E459|Transformed_cell_line|Homo sapiens | denotes | APD |
T8 | 1023-1026 | CVCL_E459|Transformed_cell_line|Homo sapiens | denotes | APD |
T9 | 1110-1111 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
T10 | 1187-1190 | CVCL_E459|Transformed_cell_line|Homo sapiens | denotes | APD |
T11 | 1281-1287 | CVCL_0238|Cancer_cell_line|Homo sapiens | denotes | change |
T12 | 1377-1383 | CVCL_0238|Cancer_cell_line|Homo sapiens | denotes | change |
T13 | 1387-1390 | CVCL_E459|Transformed_cell_line|Homo sapiens | denotes | APD |
T14 | 1480-1481 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
T15 | 1689-1692 | CVCL_6758|Undefined_cell_line_type|Cricetulus griseus | denotes | has |
T16 | 1689-1692 | CVCL_E689|Transformed_cell_line|Homo sapiens | denotes | has |
T17 | 1693-1694 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
T18 | 1829-1832 | CVCL_E773|Transformed_cell_line|Homo sapiens | denotes | may |
GoldHamster
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 62-74 | 8727 | denotes | progesterone |
T1 | 62-74 | D011374 | denotes | progesterone |
T3 | 62-74 | CHEBI:17026 | denotes | progesterone |
T4 | 62-74 | D011374 | denotes | progesterone |
T5 | 117-121 | CHEBI:23888 | denotes | drug |
T6 | 155-161 | UBERON:0003100 | denotes | female |
T7 | 162-169 | D011817 | denotes | rabbits |
T8 | 162-169 | 9986 | denotes | rabbits |
T12 | 196-205 | 4083 | denotes | estradiol |
T9 | 196-205 | CHEBI:16469 | denotes | estradiol |
T10 | 196-205 | CHEBI:23965 | denotes | estradiol |
T11 | 196-205 | D004958 | denotes | estradiol |
T13 | 196-205 | D004958 | denotes | estradiol |
T15 | 210-222 | 8727 | denotes | progesterone |
T14 | 210-222 | D011374 | denotes | progesterone |
T16 | 210-222 | CHEBI:17026 | denotes | progesterone |
T17 | 210-222 | D011374 | denotes | progesterone |
T18 | 285-305 | CHEBI:38070 | denotes | antiarrhythmic agent |
T19 | 344-351 | D011817 | denotes | rabbits |
T20 | 344-351 | 9986 | denotes | rabbits |
T21 | 429-437 | D006728 | denotes | hormones |
T22 | 429-437 | D006728 | denotes | hormones |
T23 | 429-437 | CHEBI:24621 | denotes | hormones |
T25 | 480-492 | 8727 | denotes | progesterone |
T24 | 480-492 | D011374 | denotes | progesterone |
T26 | 480-492 | CHEBI:17026 | denotes | progesterone |
T27 | 480-492 | D011374 | denotes | progesterone |
T31 | 497-506 | 4083 | denotes | estradiol |
T28 | 497-506 | CHEBI:16469 | denotes | estradiol |
T29 | 497-506 | CHEBI:23965 | denotes | estradiol |
T30 | 497-506 | D004958 | denotes | estradiol |
T32 | 497-506 | D004958 | denotes | estradiol |
T33 | 567-574 | UBERON:0001015 | denotes | muscles |
T34 | 578-584 | UBERON:0003100 | denotes | female |
T36 | 585-591 | 813859 | denotes | rabbit |
T35 | 585-591 | D011817 | denotes | rabbit |
T37 | 585-591 | 9986 | denotes | rabbit |
T38 | 612-617 | CHEBI:131189 | denotes | glass |
T40 | 664-676 | 8727 | denotes | progesterone |
T39 | 664-676 | D011374 | denotes | progesterone |
T41 | 664-676 | CHEBI:17026 | denotes | progesterone |
T42 | 664-676 | D011374 | denotes | progesterone |
T43 | 687-703 | GO:0001508 | denotes | action potential |
T44 | 737-740 | CVCL_E459 | denotes | APD |
T48 | 754-763 | 4083 | denotes | estradiol |
T45 | 754-763 | CHEBI:16469 | denotes | estradiol |
T46 | 754-763 | CHEBI:23965 | denotes | estradiol |
T47 | 754-763 | D004958 | denotes | estradiol |
T49 | 754-763 | D004958 | denotes | estradiol |
T50 | 774-777 | CVCL_E459 | denotes | APD |
T51 | 803-806 | CVCL_E459 | denotes | APD |
T52 | 849-857 | D006728 | denotes | hormones |
T53 | 849-857 | D006728 | denotes | hormones |
T54 | 849-857 | CHEBI:24621 | denotes | hormones |
T85 | 919-927 | D006728 | denotes | hormones |
T86 | 919-927 | D006728 | denotes | hormones |
T87 | 919-927 | CHEBI:24621 | denotes | hormones |
T88 | 931-934 | CVCL_E459 | denotes | APD |
T89 | 1023-1026 | CVCL_E459 | denotes | APD |
T91 | 1034-1046 | 8727 | denotes | progesterone |
T90 | 1034-1046 | D011374 | denotes | progesterone |
T92 | 1034-1046 | CHEBI:17026 | denotes | progesterone |
T93 | 1034-1046 | D011374 | denotes | progesterone |
T98 | 1187-1190 | CVCL_E459 | denotes | APD |
T102 | 1198-1207 | 4083 | denotes | estradiol |
T99 | 1198-1207 | CHEBI:16469 | denotes | estradiol |
T100 | 1198-1207 | CHEBI:23965 | denotes | estradiol |
T101 | 1198-1207 | D004958 | denotes | estradiol |
T103 | 1198-1207 | D004958 | denotes | estradiol |
T108 | 1387-1390 | CVCL_E459 | denotes | APD |
T110 | 1459-1469 | 49247 | denotes | dofetilide |
T109 | 1459-1469 | CHEBI:4681 | denotes | dofetilide |
T111 | 1459-1469 | C063533 | denotes | dofetilide |
T112 | 1459-1469 | C063533 | denotes | dofetilide |
T117 | 1492-1512 | CHEBI:38070 | denotes | antiarrhythmic agent |
T118 | 1564-1571 | UBERON:0001015 | denotes | muscles |
T120 | 1588-1600 | 8727 | denotes | progesterone |
T119 | 1588-1600 | D011374 | denotes | progesterone |
T121 | 1588-1600 | CHEBI:17026 | denotes | progesterone |
T122 | 1588-1600 | D011374 | denotes | progesterone |
T126 | 1631-1640 | 4083 | denotes | estradiol |
T123 | 1631-1640 | CHEBI:16469 | denotes | estradiol |
T124 | 1631-1640 | CHEBI:23965 | denotes | estradiol |
T125 | 1631-1640 | D004958 | denotes | estradiol |
T127 | 1631-1640 | D004958 | denotes | estradiol |
T129 | 1676-1688 | 8727 | denotes | progesterone |
T128 | 1676-1688 | D011374 | denotes | progesterone |
T130 | 1676-1688 | CHEBI:17026 | denotes | progesterone |
T131 | 1676-1688 | D011374 | denotes | progesterone |
T132 | 1695-1702 | SO:0001031 | denotes | reverse |
T136 | 1758-1767 | 4083 | denotes | estradiol |
T133 | 1758-1767 | CHEBI:16469 | denotes | estradiol |
T134 | 1758-1767 | CHEBI:23965 | denotes | estradiol |
T135 | 1758-1767 | D004958 | denotes | estradiol |
T137 | 1758-1767 | D004958 | denotes | estradiol |
T138 | 1788-1814 | GO:0060307 | denotes | ventricular repolarization |
T139 | 1788-1814 | GO:0098915 | denotes | ventricular repolarization |
T141 | 1816-1828 | 8727 | denotes | progesterone |
T140 | 1816-1828 | D011374 | denotes | progesterone |
T142 | 1816-1828 | CHEBI:17026 | denotes | progesterone |
T143 | 1816-1828 | D011374 | denotes | progesterone |
T144 | 1844-1858 | D004198 | denotes | susceptibility |
T145 | 1844-1858 | D004198 | denotes | susceptibility |
PubmedHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 314-325 | HP_0011675 | denotes | arrhythmias |